| Not Yet Recruiting | A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas NCT04745156 | Medical College of Wisconsin | N/A |
| Not Yet Recruiting | DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) NCT07398066 | University of Malaya | N/A |
| Not Yet Recruiting | Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During NCT07493447 | Eben Rosenthal | EARLY_Phase 1 |
| Not Yet Recruiting | Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 / Phase 2 |
| Not Yet Recruiting | Precision Radiotherapy Enabled by Molecular MRI NCT07512154 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Recruiting | Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EG NCT07326566 | Black Diamond Therapeutics, Inc. | Phase 2 |
| Not Yet Recruiting | Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) NCT07210632 | Eben Rosenthal | EARLY_Phase 1 |
| Recruiting | Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors NCT07374692 | National Cancer Institute (NCI) | N/A |
| Not Yet Recruiting | Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Sur NCT07313709 | University of Cincinnati | N/A |
| Recruiting | Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Gliobla NCT06991101 | Baptist Health South Florida | Phase 2 |
| Recruiting | HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) NCT06930846 | Dartmouth-Hitchcock Medical Center | N/A |
| Withdrawn | Head Stabilization in Whole Brain RT NCT06776406 | Abramson Cancer Center at Penn Medicine | N/A |
| Enrolling By Invitation | Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pa NCT07307157 | Harvard Medical School (HMS and HSDM) | — |
| Recruiting | TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas NCT06640582 | Essen Biotech | Phase 1 / Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | 18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery NCT06048094 | Baptist Health South Florida | Phase 1 |
| Completed | Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptabil NCT06168825 | Inova Health Care Services | — |
| Recruiting | SGM-101 in Colorectal Brain Metastases. NCT04755920 | Leiden University Medical Center | Phase 2 |
| Completed | CALM: Managing Distress in Malignant Brain Cancer NCT06180460 | Virginia Commonwealth University | N/A |
| Recruiting | Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer NCT06058988 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma NCT05954858 | Northwell Health | N/A |
| Recruiting | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors NCT05961111 | Shanghai Yunying Medical Technology | EARLY_Phase 1 |
| Terminated | A Virtually Delivered Exercise Intervention To Mitigate Cognitive Deficits From Radiotherapy In AYAs With Brai NCT05554159 | M.D. Anderson Cancer Center | N/A |
| Completed | Contextualized Neuropsychological Rehabilitation for CNS Cancer Survivors: The ImPACT Program NCT05858359 | Aarhus University Hospital | N/A |
| Recruiting | Record Voxel Rate Nonlinear Optical Microscope to Unravel Brain Connectome and Signaling NCT05943262 | National Taiwan University Hospital | — |
| Recruiting | Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) NCT05979064 | Northwell Health | N/A |
| Unknown | Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System NCT05549414 | P-Cure | N/A |
| Recruiting | HRQoL in Patients With Solid Tumors Treated With Hadrontherapy NCT05947149 | CNAO National Center of Oncological Hadrontherapy | — |
| Recruiting | LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology NCT05184790 | University of Sydney | — |
| Recruiting | Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis NCT05554302 | Baptist Health South Florida | Phase 2 |
| Recruiting | Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. NCT05686798 | Henry Ford Health System | Phase 1 |
| Terminated | Forgotten Voices: Addressing Unmet Needs in Brain Tumor Caregivers NCT05590273 | Virginia Commonwealth University | N/A |
| Completed | Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy NCT05427214 | Washington University School of Medicine | N/A |
| Completed | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors NCT05131815 | Cedars-Sinai Medical Center | N/A |
| Completed | Brain Tumor Intraoperative Ultrasound Database NCT05062772 | Hospital del Rio Hortega | — |
| Terminated | Pembro+Chemo in Brain Mets NCT04964960 | John L. Villano, MD, PhD | Phase 2 |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Unknown | Controlling Coordination After Childhood Cerebellar Cancer, a Pilot Study NCT04501731 | University of Nottingham | — |
| Recruiting | Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation NCT05271240 | Northwell Health | Phase 3 |
| Completed | Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors NCT05169944 | University of California, San Francisco | Phase 1 |
| Recruiting | Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radio NCT04689048 | Baptist Health South Florida | Phase 1 |
| Unknown | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors NCT05116137 | Nova Scotia Health Authority | N/A |
| Recruiting | Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study NCT04962672 | University Health Network, Toronto | N/A |
| Recruiting | Wearable Devices and Biomarkers Project (Healthiomics) NCT05106725 | CureScience | — |
| Active Not Recruiting | Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases NCT04899908 | Brigham and Women's Hospital | Phase 2 |
| Active Not Recruiting | A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors NCT05023434 | Medical College of Wisconsin | — |
| Active Not Recruiting | Tempus Priority Study: A Pan-tumor Observational Study NCT05179824 | Tempus AI | — |
| Unknown | Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients. NCT04367779 | Centre Leon Berard | — |
| Completed | Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors NCT04704804 | Institut Cancerologie de l'Ouest | — |
| Completed | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 | Quadriga Biosciences, Inc. | Phase 1 |
| Active Not Recruiting | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors NCT04478279 | Sapience Therapeutics | Phase 1 / Phase 2 |
| Withdrawn | Single vs Multi-fraction SRS Patients on Immunotherapy NCT04427228 | University of Chicago | Phase 2 |
| Unknown | Radiomic Analysis for Predicting Treatment Response and Clinical Outcomes in Malignancies NCT05170087 | Sunnybrook Health Sciences Centre | — |
| Completed | Electronic Social Network Assessment Program (eSNAP) + Caregiver Navigator NCT04268979 | H. Lee Moffitt Cancer Center and Research Institute | N/A |
| Suspended | Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recu NCT04222309 | Northwell Health | Phase 1 |
| Terminated | Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI): A Prospective Pilot Study NCT04047602 | Indiana University | N/A |
| Completed | PET and MRI Imaging of Brain Tumors Using [18F]PARPi NCT04173104 | Memorial Sloan Kettering Cancer Center | EARLY_Phase 1 |
| Completed | 3D Printed Mask for GBM and Brain Mets NCT04114786 | University Health Network, Toronto | N/A |
| Completed | Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescen NCT04023669 | St. Jude Children's Research Hospital | Phase 1 |
| Completed | Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas NCT03925246 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Terminated | Neurosurgical Transitional Care Programme NCT03593330 | Barts & The London NHS Trust | N/A |
| Recruiting | The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients. NCT03861299 | Jasper Gerritsen | N/A |
| Active Not Recruiting | Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. NCT03972514 | Baptist Health South Florida | — |
| Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305 | UMC Utrecht | — |
| Completed | Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With Hi NCT03538587 | National Cancer Institute (NCI) | N/A |
| Active Not Recruiting | Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM NCT03630289 | Northwell Health | N/A |
| Withdrawn | Study to Develop Head Stabilizer for Use During Brain Radiation Therapy NCT03629964 | University of Chicago | N/A |
| Terminated | Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton NCT03403361 | Washington University School of Medicine | N/A |
| Terminated | T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Br NCT03190967 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors NCT03465618 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262 | St. Jude Children's Research Hospital | Phase 1 |
| Completed | Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Express NCT03050736 | Kintara Therapeutics, Inc. | Phase 2 |
| Terminated | VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM NCT03149575 | DelMar Pharmaceuticals, Inc. | Phase 3 |
| Unknown | Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastom NCT03294486 | Assistance Publique - Hôpitaux de Paris | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 NCT03152318 | Dana-Farber Cancer Institute | Phase 1 |
| Recruiting | Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM NCT03213002 | Northwell Health | Phase 1 / Phase 2 |
| Enrolling By Invitation | Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme NCT03170141 | Shenzhen Geno-Immune Medical Institute | Phase 1 |
| Completed | Refining and Testing the Electronic Social Network Assessment Program (eSNAP) NCT03026699 | H. Lee Moffitt Cancer Center and Research Institute | — |
| Completed | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma NCT03072134 | Northwestern University | Phase 1 |
| Completed | A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery NCT03115398 | Montefiore Medical Center | N/A |
| Completed | Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurre NCT02717962 | Kintara Therapeutics, Inc. | Phase 2 |
| Completed | Re-craniotomy and Complications After Elective Neurosurgery NCT03910556 | Chiang Mai University | — |
| Completed | Safety Study of Afatinib for Brain Cancer NCT02423525 | Santosh Kesari | Phase 1 |
| Completed | Correlation Between Circulating Tumor Cells and Brain Disease Control After Focal Radiotherapy for Metastases NCT02941536 | AC Camargo Cancer Center | N/A |
| Completed | Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects NCT02798406 | DNAtrix, Inc. | Phase 2 |
| Completed | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists NCT02911155 | National Cancer Institute (NCI) | — |
| Active Not Recruiting | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibi NCT02852655 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | Natural History of and Specimen Banking for People With Tumors of the Central Nervous System NCT02851706 | National Cancer Institute (NCI) | — |
| Completed | Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade NCT02849171 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastom NCT02861898 | Northwell Health | Phase 1 / Phase 2 |
| Recruiting | Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Re NCT02800486 | Northwell Health | Phase 2 |
| Completed | Early Life Exposures in Agriculture NCT02743481 | National Cancer Institute (NCI) | — |
| Recruiting | Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker NCT02691923 | David W. Roberts | Phase 2 |
| Completed | An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Thera NCT02617589 | Bristol-Myers Squibb | Phase 3 |
| Completed | Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) NCT02808416 | Guangdong 999 Brain Hospital | Phase 1 |
| Terminated | Biomarker Analysis of Central Nervous System Tumors NCT02692898 | National Cancer Institute (NCI) | — |
| Completed | IDH1 Peptide Vaccine for Recurrent Grade II Glioma NCT02193347 | Katy Peters, MD, PhD | Phase 1 |
| Withdrawn | More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery NCT01445691 | Constantinos Hadjipanayis | Phase 2 |
| Completed | 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients NCT02334722 | University of Florida | Phase 4 |
| Completed | Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients NCT02457715 | Duke University | — |
| Completed | Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of th NCT02452216 | Michael Iv | EARLY_Phase 1 |
| Terminated | Cambridge Brain Mets Trial 1 NCT02768337 | Cambridge University Hospitals NHS Foundation Trust | Phase 1 / Phase 2 |
| Active Not Recruiting | Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers NCT02375841 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in NCT02708056 | Baskent University | Phase 4 |
| Terminated | PET Imaging of Intracranial Cancers With 18F-FSPG NCT02370563 | Life Molecular Imaging SA | Phase 1 |
| Withdrawn | 18-F-Fluoroacetate as PET Imaging Agent NCT01320787 | M.D. Anderson Cancer Center | Phase 1 |
| Terminated | A Phase II Study of Dacomitinib in Progressive Brain Metastases NCT02047747 | David Piccioni, M.D., Ph.D | Phase 2 |
| Completed | Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressin NCT02045368 | IGF Oncology, LLC | Phase 1 |
| Completed | Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis NCT01974804 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas NCT01849952 | Dartmouth-Hitchcock Medical Center | — |
| Terminated | Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors NCT01902771 | Edward Ziga | Phase 1 |
| Active Not Recruiting | Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma NCT01892397 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT) NCT01854554 | M.D. Anderson Cancer Center | Phase 2 |
| Withdrawn | Phase I/II Cabazitaxel for Recurrent Malignant Glioma NCT01740570 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water NCT01246869 | University of Utah | Phase 1 |
| Terminated | Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS0 NCT01987193 | University of Florida | — |
| Unknown | Synchrotron Radiation to the Treatment of Intracranial Tumors NCT01640509 | University Hospital, Grenoble | Phase 1 / Phase 2 |
| Completed | Dexanabinol in Patients With Brain Cancer NCT01654497 | Santosh Kesari, M.D., Ph.D. | Phase 1 |
| Completed | CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII NCT01454596 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression NCT01604512 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | MRI and Diffusion Imaging of Eloquent Brain Areas to Optimize Brain Tumor Resection Planning NCT01534104 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) NCT01469247 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Convection-Enhanced Delivery of 124I-Omburtamab for Patients With Non-Progressive Diffuse Pontine Gliomas Prev NCT01502917 | Y-mAbs Therapeutics | Phase 1 |
| Completed | Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma NCT01478178 | Kintara Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma NCT01392209 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | Phase I / II Vorinostat, Erlotinib and Temozolomide for Recurrent Glioblastoma Multiforme (GBM) NCT01110876 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas NCT01058850 | Paul Graham Fisher | Phase 1 |
| Completed | A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients NCT01770626 | University of Alabama at Birmingham | EARLY_Phase 1 |
| Completed | EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas NCT01257594 | Andrew B Lassman, MD | Phase 1 |
| Terminated | Administration of CMV-Specific Cytotoxic T Cells in Patients With Glioblastoma Multiforme NCT01205334 | Baylor College of Medicine | Phase 1 / Phase 2 |
| Terminated | Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma NCT01105702 | NYU Langone Health | Phase 2 |
| Terminated | TPI 287 in Patients With Recurrent Glioblastoma Multiforme NCT01113463 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multifo NCT01067469 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Optimal Planning Target Volume With Stereotactic Radiosurgery NCT01017497 | Duke University | N/A |
| Terminated | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors NCT01014767 | Tufts Medical Center | Phase 3 |
| Completed | External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adul NCT01012609 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Image-Guided Stereotactic Biopsy of High Grade Gliomas NCT00979810 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Bevacizumab and Lapatinib in Children With Recurrent or Refractory Ependymoma NCT00883688 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lun NCT00946673 | Stanford University | Phase 1 |
| Completed | Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases NCT00928226 | Stanford University | N/A |
| Completed | Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer NCT00871923 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lympho NCT01065805 | AHS Cancer Control Alberta | Phase 1 / Phase 2 |
| Recruiting | Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design NCT00870129 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas NCT00805376 | DNAtrix, Inc. | Phase 1 |
| Completed | Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients NCT00876499 | M.D. Anderson Cancer Center | — |
| Completed | [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors NCT00832598 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma NCT00782756 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors NCT00747253 | Monteris Medical | Phase 1 |
| Terminated | Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinot NCT00636805 | Duke University | Phase 2 |
| Completed | Combination of Hydroxyurea and Verapamil for Refractory Meningiomas NCT00706810 | University of Utah | Phase 2 |
| Completed | Phase I, Open Label, Single Center Safety Study of [F-18]FLT NCT00553748 | Siemens Molecular Imaging | Phase 1 |
| Unknown | Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer NCT00045968 | Northwest Biotherapeutics | Phase 3 |
| Completed | MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Prim NCT00392119 | BioTex, Inc. | Phase 1 |
| Completed | Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue NCT00723463 | University of Michigan | EARLY_Phase 1 |
| Completed | Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas NCT00590954 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Experience of Brain Tumor Caregivers NCT00352820 | M.D. Anderson Cancer Center | — |
| Completed | Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma NCT00595322 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples NCT01650922 | Stanford University | — |
| Completed | A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patie NCT00329589 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Language Function in Patients With Brain Tumors NCT00599703 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and R NCT00185848 | Sanjiv Sam Gambhir | Phase 1 |
| Completed | Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors NCT00594633 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Urban Environmental Exposures and Childhood Cancer NCT00505141 | Georgetown University | — |
| Completed | Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma NCT00185861 | Stanford University | Phase 1 |
| Completed | 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients NCT00504660 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Imaging Brain Tumors With FACBC and Methionine NCT00597246 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Study of Health Effects of Cosmetic Breast Augmentation NCT00342953 | National Cancer Institute (NCI) | — |
| Terminated | Consent for Obtaining Additional Bone Marrow Specimens at Time of Diagnostic Bone Marrow Procedure NCT01048060 | Stanford University | — |
| Completed | Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy NCT00548756 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid NCT00241670 | medac GmbH | Phase 3 |
| Completed | (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy NCT00001807 | National Cancer Institute (NCI) | — |
| Completed | Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial NCT00460395 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women NCT00342004 | National Cancer Institute (NCI) | — |
| Completed | A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric Patients With Primary and Me NCT00001574 | National Cancer Institute (NCI) | — |
| Completed | Spectroscopy With Surface Coils and Decoupling NCT00581815 | Memorial Sloan Kettering Cancer Center | Phase 1 |